Most caregivers do not need genetic testing simply because they provide care. Testing is worth considering when your own personal or family history points to inherited risk. Genetic testing means a lab test that looks for inherited gene changes that raise risk for disease. Caregivers who are blood relatives share the care recipient's family history, so a parent's early-onset Alzheimer's or a sister's ovarian cancer can be relevant to your own risk.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- When family history changes the decision
- What Alzheimer genes can and cannot tell you
- Why experts urge counseling first, not home kits
- Practical next steps for caregivers
When family history changes the decision
Caring for someone with cancer does not mean you carry the same mutation. Trualta caregiver education notes that only about 5 to 10 percent of cancers come from an inherited mutation, with most acquired during life, in Trualta's facts for caregivers. The National Cancer Institute says inherited-cancer testing usually follows review of personal and family history, ideally starting with an affected relative.
Women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer, or BRCA-associated ancestry, should receive a brief familial risk tool, then counseling and testing if indicated. For dementia families, APOE-e4 is the strongest known Alzheimer risk gene, estimated to play a role in up to one-quarter of cases. Deterministic APP, PSEN1, and PSEN2 mutations directly cause rare early-onset disease.
What Alzheimer genes can and cannot tell you
APOE-e4 is a susceptibility gene, not a diagnosis. Having one or two copies raises risk, but many carriers never develop dementia and many patients lack the variant. APP, PSEN1, and PSEN2 are different because they can directly cause disease.
Testing for them is targeted to early-onset or autosomal-dominant families, where disease passes from parent to child across generations. A key limit is that susceptibility variants such as APOE have poor predictive value for any one person. Results can cause lasting worry without offering a drug or lifestyle step that removes risk.
Why experts urge counseling first, not home kits
The joint National Society of Genetic Counselors practice resource advises against routine or direct-to-consumer APOE testing, in the NSGC guidance summary. It calls for expert pre- and post-test counseling with a three-generation pedigree. Counseling maps who had what illness, at what age, and on which side of the family.
That detail helps decide whether any test would change screening, prevention, or family planning. Home results arrive without that context or support. A counselor can explain a positive, negative, or uncertain result and discuss next steps for relatives.
Practical next steps for caregivers
If you pursue testing, federal GINA Title II protects employment decisions. The U.S. Equal Employment Opportunity Commission states that employers with 15 or more employees cannot use genetic information in hiring, firing, pay, or promotion, in the EEOC GINA fact sheet.
- Write down cancers, dementias, and ages at diagnosis for parents, siblings, grandparents, aunts, and uncles
- Note your own health history, including breast, ovarian, tubal, or peritoneal cancer
- Ask your clinician whether referral to a genetic counselor fits your pattern
- Do not order APOE testing on your own while you are deciding
